Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bringing immunofocusing into focus
Sriharshita Musunuri, Payton A. Weidenbacher, Peter S. Kim
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Vaccine design via antigen reorientation
Duo Xu, Joshua Carter, Chunfeng Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 8, pp. 1012-1021
Open Access | Times Cited: 18
RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2
Rang Feng, Ruo‐Yi Xue, Chang Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Structure-based design of an immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccine
Natalie C. Silmon de Monerri, Ye Che, Joshua A. Lees, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 2, pp. e1012325-e1012325
Open Access | Times Cited: 1
Influence of membrane on the antigen presentation of the HIV-1 envelope membrane proximal external region (MPER)
César A. López, S. Munir Alam, Cynthia A. Derdeyn, et al.
Current Opinion in Structural Biology (2024) Vol. 88, pp. 102897-102897
Closed Access | Times Cited: 7
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 4
Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing
Sonia Bhattacharya, Matthew C. Jenkins, Parisa Keshavarz-Joud, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20083-20100
Open Access | Times Cited: 4
Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies
Mario Fragoso-Saavedra, Qiang Liu
Virology (2025) Vol. 604, pp. 110412-110412
Closed Access
Rethinking Optimal Immunogens to Face SARS‐CoV‐2 Evolution Through Vaccination
Julià Blanco, Benjamin Trinité, Joan Puig‐Barberà
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 1
Open Access
A type-specific B-cell epitope at the apex of outer surface protein C (OspC) of the Lyme disease spirochete, Borreliella burgdorferi
David J. Vance, Grace Freeman-Gallant, K. F. McCarthy, et al.
Microbiology Spectrum (2025)
Open Access
Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
Pramila Rijal, Leiyan Wei, Guido C. Paesen, et al.
(2025)
Open Access
Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
Pramila Rijal, Leiyan Wei, Guido C. Paesen, et al.
(2025)
Open Access
The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines
Irene Jurado‐Martín, Julen Tomás‐Cortázar, Nouran Rezk, et al.
Vaccine (2025) Vol. 56, pp. 127145-127145
Open Access
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
Yen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access
Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
Pramila Rijal, Leiyan Wei, Guido C. Paesen, et al.
(2025)
Open Access
An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies
Napon Nilchan, Romchat Kraivong, Prasit Luangaram, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 8, pp. 2690-2704
Open Access | Times Cited: 2
Advances in protein subunit vaccines against H1N1/09 influenza
Yu Zhang, Jingyao Gao, Wenqi Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors
Masaud Shah, Sobia Rafiq, Hyun Goo Woo
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 2
Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial
María Jesús López Fernandez, Silvia Narejos, Antoni Castro-Guardiola, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Structure-Based Design of a Highly Immunogenic, Conformationally Stabilized FimH Antigen for a Urinary Tract Infection Vaccine
Natalie C. Silmon de Monerri, Ye Che, Joshua A. Lees, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
ACS Central Science (2024) Vol. 10, Iss. 10, pp. 1871-1884
Open Access | Times Cited: 1
Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing
Sonia Bhattacharya, Matthew C. Jenkins, Parisa Keshavarz-Joud, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results
María Jesús López Fernández, Silvia Narejos, Antoni Castro-Guardiola, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 840-840
Open Access
Loop Grafting Improves Neuraminidase Protein Vaccine Production
Pramila Rijal, Leiyan Wei, Guido C. Paesen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
MERS-CoV Spike Vaccine-induced N-Terminal Domain-specific Antibodies are More Protective than Receptor Binding Domain-specific Antibodies
Olubukola M. Abiona, Nianshuang Wang, Sarah R. Leist, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111632-111632
Open Access
Page 1

Scroll to top